These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20933614)

  • 1. Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F.
    Fritzler MJ; Rattner JB; Luft LM; Edworthy SM; Casiano CA; Peebles C; Mahler M
    Autoimmun Rev; 2011 Feb; 10(4):194-200. PubMed ID: 20933614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
    Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
    Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
    Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
    Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
    Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
    J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis.
    Rattner JB; Rees J; Arnett FC; Reveille JD; Goldstein R; Fritzler MJ
    Arthritis Rheum; 1996 Aug; 39(8):1355-61. PubMed ID: 8702444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
    Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
    J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-centromere autoantibody in a patient evolving from a lupus/Sjögren's overlap to the CREST variant of scleroderma.
    Ford AL; Kurien BT; Harley JB; Scofield RH
    J Rheumatol; 1998 Jul; 25(7):1419-24. PubMed ID: 9676778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.
    Bencimon C; Salles G; Moreira A; Guyomard S; Coiffier B; Bienvenu J; Fabien N
    Ann N Y Acad Sci; 2005 Jun; 1050():319-26. PubMed ID: 16014548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-histone autoantibodies recognize centromeric heterochromatin in metaphase chromosomes and hidden epitopes in interphase cells.
    Burlingame RW; Rubin RL
    Hum Antibodies Hybridomas; 1992 Jan; 3(1):40-7. PubMed ID: 1374273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity to the cell cycle-dependent centromere protein p330d/CENP-F in disorders associated with cell proliferation.
    Casiano CA; Humbel RL; Peebles C; Covini G; Tan EM
    J Autoimmun; 1995 Aug; 8(4):575-86. PubMed ID: 7492351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay.
    Welner S; Trier NH; Frisch M; Locht H; Hansen PR; Houen G
    Mol Cancer; 2013 Aug; 12(1):95. PubMed ID: 23978088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization.
    Rattner JB; Rao A; Fritzler MJ; Valencia DW; Yen TJ
    Cell Motil Cytoskeleton; 1993; 26(3):214-26. PubMed ID: 7904902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.